Discussion
U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
Discussion
A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…
Discussion
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Discussion
Some mornings the mirror catches me off guard. I know this might sound strange, especially when one is new to caregiving. But I haven’t just…
Discussion
Adults in the U.S. now have a new generic drug option — Bortezomib for Injection, an equivalent of the approved medication Velcade (bortezomib) —…
Discussion
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
